The Clinical PD Biomarkers Program is responsible for identification of biomarkers of response to new targeted agents entering clinical trials in the Developmental Therapeutics Program of the National Cancer Institute. The scope of work includes assay design, development, validation, fitness for purpose testing, transfer of assays to clinical laboratories, and clinical specimen analysis when required. The program facilitates mechanistic and performance analysis of putative anti-cancer agents, diagnostic tests, and therapeutic interventions to clinical applications, including distinct molecular signatures for cancer, refined molecular assays, and state-of-the-art imaging techniques that are too high-risk for industry or academia to pursue.
The postdoctoral fellow will be responsible for sssisting in the development, validation, and application of quantitative multiplex assays of non-apoptotic cell death mechanisms on the Luminex platform to be used in assessing patient response to new anti-cancer agents. Designing ex vivo and in vivo experiments to test immunoassay reagents and efficacy of assays; designing antigens for generation of antibodies; writing statements of work for sub-contracted work; monitoring development of monoclonal antibodies;
producing and characterizing recombinant proteins and/or peptides as calibrators; developing and validating multiplex immunoassays of pharmacodynamic biomarkers on Luminex platform; ensuring adequate specificity and analytical characteristics of reagents; providing timely progress reports to Principal Scientist and preparing/performing presentations for management review; and writing abstracts/manuscripts for presentations in meetings and publication.
- Knowledge about apoptosis and non-apoptotic cell death pathways.
- Knowledge of techniques used in development, production, and characterization of reagents used in immunoassays such as antibodies and recombinant proteins
- Immunoassay data analysis and concepts in immunoassay quality control/good laboratory practice standards.
To be considered for this position, you must minimally meet the knowledge, skills, and abilities listed below:
- Possession of a Doctoral degree from an accredited college or university according to the Council for Higher Education Accreditation in a field related to pharmacology, molecular pharmacology, experimental therapeutics, cancer therapy or drug development. Foreign degrees will be evaluated for U.S. equivalency
- No additional experience required for candidates with a Doctoral degree
- Must be able to obtain and maintain a security clearance
Candidates with these desired skills will be given preferential consideration:
- Research performed in the area of understanding mechanisms of apoptotic and non-apoptotic cell death pathways.
- Experience in molecular biology techniques, protein/antibody characterization, and in vitro testing of inhibitors of apoptosis.
- Knowledge of statistics applied in data reduction and analysis.
This position is subject to a background investigation.